YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
about
Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseYKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.Role of breast regression protein-39/YKL-40 in asthma and allergic responsesIn vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African childrenThe chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's diseaseThe chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.Cancer risk by combined levels of YKL-40 and C-reactive protein in the general populationChitinase-like proteins in lung injury, repair, and metastasisChitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.Human chitinases and chitinase-like proteins as indicators for inflammation and cancerPotential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patientsYKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.Progress update: fluid and imaging biomarkers in Alzheimer's disease.Brain barriers and a subpopulation of astroglial progenitors of developing human forebrain are immunostained for the glycoprotein YKL-40.Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.Chitin regulation of immune responses: an old molecule with new roles.Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.Urinary YKL-40 as a Candidate Biomarker for Febrile Urinary Tract Infection in Young Children.Circulating YKL-40 levels during human endotoxaemia.Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
P2860
Q24656942-77BE9B28-8710-41C1-BD68-A6ADA0894A47Q28743561-A2B20574-B89B-482F-AC5C-DF467C6697C2Q33343967-8DD4542E-25E8-4089-8D36-F16CF6FCB6B9Q33701312-36CA65FD-3870-4CCD-8622-75DB9F0466A9Q33942238-41C00302-198F-4BBF-9C9C-DF3CF4CF7DCDQ33965057-C9EE07EE-071A-4692-A010-8FC2DDFE4994Q34031351-DA74EA9A-10E7-420E-8563-779A56C5D16FQ34269049-0408B103-42E0-4BD9-BE2E-0A720544A3A1Q34447497-342DF136-B86B-47E5-80D0-1A27A93C94EFQ34479904-AB43BACF-49CE-4A2B-B77D-6A33A0163EC9Q35653750-DE48F269-C39B-41C9-955D-EC2AFB168C32Q35984042-6DDF8EB6-B3EC-4396-836F-DD0139854281Q36731284-317C840E-7970-4A27-AA27-64F51A73C65FQ37075990-27EBBF58-2C03-40C1-9210-429F22528C3AQ37273123-E9598188-B49F-4E0F-A202-A8290559A1ABQ37279929-00A09A22-AC7B-465E-94A3-17F0EF79AA61Q37280948-FF8B99B4-9DA9-422D-B996-0F4FCDD25539Q37298658-3FB91285-4BCE-43E9-AA6A-230CDE920CDCQ37334247-1CF79894-2ACE-4837-9BDE-1A26F3FFEEF4Q37375527-660F1F12-0491-462A-A207-7EDFADA4C61EQ37482262-C0529026-CB97-4B22-BAAE-23D3125765C2Q37626382-79E72F73-080D-4A33-A85F-498AA92F9B2FQ37733730-9887B162-9DA0-4B8A-8FC4-C29E81C9B7B2Q37807414-669DEAF7-F553-469F-93F6-814BE6811597Q43225380-3ECBCB83-CDEE-4A56-AE55-69D3DC1E2B1AQ48092406-CBB6D545-63D5-4CD7-8D28-EE8DAD19B7C5Q49167559-B3A415FF-7F7F-45B8-86E9-8B6F9ADBDA84Q54488554-710A04AC-2C0F-42AD-87F3-57350333CDF4Q58122618-5D512085-1382-4CA9-8711-E36F29D7E5C3
P2860
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@ast
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en-gb
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@nl
type
label
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@ast
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en-gb
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@nl
prefLabel
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@ast
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en-gb
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@nl
P2093
P2860
P921
P3181
P1476
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis
@en
P2093
Christian Østergaard
Julia S Johansen
Paul A Price
Thomas Benfield
P2860
P304
P3181
P356
10.1128/CDLI.9.3.598-604.2002
P407
P577
2002-05-01T00:00:00Z